99 related articles for article (PubMed ID: 35956550)
21.
Singh P; Tripathi MK; Yasir M; Khare R; Shrivastava R
Mol Biol Res Commun; 2021 Sep; 10(3):131-140. PubMed ID: 34476266
[TBL] [Abstract][Full Text] [Related]
22. Metabologenomics approach to the discovery of novel compounds from
Melinda YN; Widada J; Wahyuningsih TD; Febriansah R; Damayanti E; Mustofa M
Heliyon; 2021 Nov; 7(11):e08308. PubMed ID: 34746476
[TBL] [Abstract][Full Text] [Related]
23. Identification of a novel dual-target scaffold for 3CLpro and RdRp proteins of SARS-CoV-2 using 3D-similarity search, molecular docking, molecular dynamics and ADMET evaluation.
Aouidate A; Ghaleb A; Chtita S; Aarjane M; Ousaa A; Maghat H; Sbai A; Choukrad M; Bouachrine M; Lakhlifi T
J Biomol Struct Dyn; 2021 Aug; 39(12):4522-4535. PubMed ID: 32552534
[TBL] [Abstract][Full Text] [Related]
24. Plant-derived natural polyphenols as potential antiviral drugs against SARS-CoV-2
Singh S; Sk MF; Sonawane A; Kar P; Sadhukhan S
J Biomol Struct Dyn; 2021 Oct; 39(16):6249-6264. PubMed ID: 32720577
[TBL] [Abstract][Full Text] [Related]
25. In Silico Identification of a Potent Arsenic Based Approved Drug Darinaparsin against SARS-CoV-2: Inhibitor of RNA Dependent RNA polymerase (RdRp) and Essential Proteases.
Chowdhury T; Roymahapatra G; Mandal SM
Infect Disord Drug Targets; 2021; 21(4):608-618. PubMed ID: 32718300
[TBL] [Abstract][Full Text] [Related]
26. Potential of Marine Terpenoids against SARS-CoV-2: An
Sahoo A; Fuloria S; Swain SS; Panda SK; Sekar M; Subramaniyan V; Panda M; Jena AK; Sathasivam KV; Fuloria NK
Biomedicines; 2021 Oct; 9(11):. PubMed ID: 34829734
[TBL] [Abstract][Full Text] [Related]
27. Repurposing of phytomedicine-derived bioactive compounds with promising anti-SARS-CoV-2 potential: Molecular docking, MD simulation and drug-likeness/ADMET studies.
Rudrapal M; Gogoi N; Chetia D; Khan J; Banwas S; Alshehri B; Alaidarous MA; Laddha UD; Khairnar SJ; Walode SG
Saudi J Biol Sci; 2022 Apr; 29(4):2432-2446. PubMed ID: 34924801
[TBL] [Abstract][Full Text] [Related]
28. Molecular modelling and simulation techniques to investigate the effects of fungal metabolites on the SARS-CoV-2 RdRp protein inhibition.
Muddapur UM; Badiger S; Shaikh IA; Ghoneim MM; Alshamrani SA; Mahnashi MH; Alsaikhan F; El-Sherbiny M; Al-Serwi RH; Khan AAL; Mannasaheb BA; Bahafi A; Iqubal SMS; Begum T; Gouse HSM; Mohammed T; Hombalimath VS
J King Saud Univ Sci; 2022 Aug; 34(6):102147. PubMed ID: 35702575
[TBL] [Abstract][Full Text] [Related]
29. Investigation of the New Inhibitors by Sulfadiazine and Modified Derivatives of α-D-glucopyranoside for White Spot Syndrome Virus Disease of Shrimp by In Silico: Quantum Calculations, Molecular Docking, ADMET and Molecular Dynamics Study.
Kumer A; Chakma U; Rana MM; Chandro A; Akash S; Elseehy MM; Albogami S; El-Shehawi AM
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744817
[TBL] [Abstract][Full Text] [Related]
30. Determination of inhibitor activity of drugs against the COVID-19.
Gedikli MA; Tuzun B; Sayin K; Ataseven H
Bratisl Lek Listy; 2021; 122(7):497-506. PubMed ID: 34161118
[TBL] [Abstract][Full Text] [Related]
31. Computational Evidences of Phytochemical Mediated Disruption of PLpro Driven Replication of SARS-CoV-2: A Therapeutic Approach against COVID-19.
Balkrishna A; Mittal R; Arya V
Curr Pharm Biotechnol; 2021; 22(10):1350-1359. PubMed ID: 33176643
[TBL] [Abstract][Full Text] [Related]
32. SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: an
Elfiky AA
J Biomol Struct Dyn; 2021 Jun; 39(9):3204-3212. PubMed ID: 32338164
[TBL] [Abstract][Full Text] [Related]
33. Discovery of Small Molecules from
Yadav P; El-Kafrawy SA; El-Day MM; Alghafari WT; Faizo AA; Jha SK; Dwivedi VD; Azhar EI
Life (Basel); 2022 Jun; 12(7):. PubMed ID: 35888042
[TBL] [Abstract][Full Text] [Related]
34. Phytoconstituents,
Youssef FS; Altyar AE; Omar AM; Ashour ML
Front Pharmacol; 2021; 12():619373. PubMed ID: 33912041
[TBL] [Abstract][Full Text] [Related]
35. Phytoconstituents from ten natural herbs as potent inhibitors of main protease enzyme of SARS-COV-2:
Kumar N; Singh A; Gulati HK; Bhagat K; Kaur K; Kaur J; Dudhal S; Duggal A; Gulati P; Singh H; Singh JV; Bedi PMS
Phytomed Plus; 2021 Nov; 1(4):100083. PubMed ID: 35403086
[TBL] [Abstract][Full Text] [Related]
36. Repurposing FDA-approved drugs against multiple proteins of SARS-CoV-2: An
Akinlalu AO; Chamundi A; Yakumbur DT; Afolayan FID; Duru IA; Arowosegbe MA; Enejoh OA
Sci Afr; 2021 Sep; 13():e00845. PubMed ID: 34308004
[TBL] [Abstract][Full Text] [Related]
37.
Maurya AK; Mishra N
J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
[TBL] [Abstract][Full Text] [Related]
38. Identification of a potential SARS-CoV2 inhibitor via molecular dynamics simulations and amino acid decomposition analysis.
Razzaghi-Asl N; Ebadi A; Shahabipour S; Gholamin D
J Biomol Struct Dyn; 2021 Oct; 39(17):6633-6648. PubMed ID: 32705953
[TBL] [Abstract][Full Text] [Related]
39. In silico identification of potential inhibitors of key SARS-CoV-2 3CL hydrolase (Mpro) via molecular docking, MMGBSA predictive binding energy calculations, and molecular dynamics simulation.
Choudhary MI; Shaikh M; Tul-Wahab A; Ur-Rahman A
PLoS One; 2020; 15(7):e0235030. PubMed ID: 32706783
[TBL] [Abstract][Full Text] [Related]
40. New Theobromine Apoptotic Analogue with Anticancer Potential Targeting the EGFR Protein: Computational and
Eissa IH; Yousef RG; Elkaeed EB; Alsfouk AA; Husein DZ; Ibrahim IM; Ismail A; Elkady H; Metwaly AM
ACS Omega; 2024 Apr; 9(14):15861-15881. PubMed ID: 38617602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
